The endothelial cell protein C receptor (EPCR) is expressed by endothelial cells of large blood vessels and by haematopoietic stem cells. DNaseI hypersensitive (DH) site mapping across 38 kb of the human EPCR gene (hEPCR) locus identified three potential regulatory elements. By itself, the DH region spanning the proximal promoter (PP) was unable to direct cell-specific transcription in transgenic mice.
Introduction
The protein C (PC) anticoagulant pathway plays a crucial role in the regulation of blood coagulation and inflammation 1 . Activated PC (APC) generated in this pathway serves to confine the haemostatic plug to the site of vascular injury by inhibiting the cofactor function of clotting factors Va and VIIIa on intact endothelium. In addition, APC may also exert anti-apoptotic and neuroprotective functions that influence inflammatory responses 2, 3 . The important regulatory roles of APC in coagulation and inflammation are illustrated by the increased risk of thrombosis incurred by individuals with deficiencies in components of the PC pathway 4 , and by the improved outcome of patients with severe sepsis treated with APC 5 .
PC is activated by thrombin, but only when thrombin is bound to its receptor, thrombomodulin, present on endothelial cells (EC). Activation is further enhanced by another EC receptor, the endothelial cell protein C receptor (EPCR) 6 . By binding PC, EPCR helps present PC to the thrombin:thrombomodulin complex and so reduces the K m for PC activation 7 . In this way, EPCR enhances APC generation by at least 5-fold in vitro 7, 8 . In vivo, blocking protein C-EPCR interactions results in a 88% decrease in circulating APC levels generated in response to thrombin infusion 9 .
EPCR function is critical for embryo development as EPCR knockout mice die in mid-gestation 10 .
The normal distribution of EPCR is highly tissue-specific. During embryogenesis, EPCR is expressed by
For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From the embryonic giant trophoblast cells from ~E7.5, and by certain embryonic EC from ~E11.5 11 . In adults, EPCR is expressed almost exclusively by EC, particularly those of larger blood vessels 12 . Its expression in microvascular EC is either very low, or absent. EPCR is, however, also expressed by primitive haematopoietic stem cells (HSC) 13 . Initial reports on the transcriptional regulation of the murine EPCR (mEPCR) 14 and human EPCR (hEPCR) 15 genes have failed to define the molecular mechanisms responsible for the rather unique in vivo cellular distribution of EPCR.
hEPCR consists of four exons that span ~5. 4 kb of genomic DNA on chromosome 20, at position q11.2 16 . mEPCR is structurally homologous to its human counterpart 17 . Transcription of hEPCR is initiated from two major sites located at -79 and -82 bp relative to the translation initiation point, and from an additional minor site at -162 bp 16, 18 . Previous investigations of the hEPCR 5'-flanking region characterised the 2.3 kb region upstream of the translation initiation site 15 , referred to as the proximal promoter (PP). In transfection studies, PP (and also truncations of this region down to -572 bp) was transcriptionally active in EC (HUVEC and EA.hy926), but not in non-EC (HepG2). Whereas these results suggested the presence of important regulatory sequences within PP that were responsible for EC-specific gene expression in vitro, it remained unclear whether PP was sufficient to confer cellspecific transcription in vivo. In this study we have identified an additional regulatory element 5.5 kb upstream of the hEPCR translation start site, which is essential for driving hEPCR expression in EC and primitive haemopoietic cells -cell types that share a common precursor.
Materials and methods

DNaseI hypersensitive site mapping
DNaseI hypersensitive (DH) sites were assayed in cultured human cells and cell lines (HUVEC, U937, HeLa, HEL, HepG2, CEM, KG1, HMC-1, peripheral blood T cells (PB-T), peripheral blood monocytes and Raji) as previously described 19 . In this study, additional DH site mapping was performed between
EcoRI sites at -3.8 and -20.3 kb, using the same probes as previously used for BamHI ( Figure 1A ).
Sequence analysis
Genomic sequences from around the human and murine EPCR loci were obtained from the Ensembl genome browser (www.ensembl.org). Sequence alignment was performed by the MAVID server and analysed using GeneDoc. Putative transcription factor binding sites within -5.5HS were identified using 
In vivo dimethylsulphate (DMS) footprinting
Plasmid constructs
pSEAP2-basic (pSB) and pSEAP2-promoter (pSP) vectors (Clontech), both containing the secreted alkaline phosphatase (SEAP) reporter gene, were used for in vitro reporter gene analysis. pSB does not contain any eukaryotic promoter, whereas pSP contains the SV40 promoter (SV40P) upstream of SEAP. The previously generated PP-pSB construct, containing -2336 to -9 bp of the hEPCR PP cloned upstream of SEAP was also used
15
. DNA sequences under investigation were PCR-amplified from either genomic DNA or the PAC clone 212-C5 (which contains hEPCR and its 5'-flanking region) using primers that introduced XhoI or SalI restriction sites for cloning. Mutation of transcription factor binding sites (Ets#1 C-5609T, GATA A-5598G, Tal1 C-5586G/T-5582C, Ets#2 C-5547T) was performed using the Quick Change XL site-directed mutagenesis kit (Stratagene). Deletion and insertion mutants were generated by inverse PCR.
For hEPCR promoter transgenes, various lengths (-1194 to -9 bp, -2336 to -9 bp, or -6 kb to -9 bp) of All transfections were performed in duplicate. Values reported are the mean of at least six independent experiments. Statistical significance of variation in reporter activity was determined by two-tailed paired t-test. All reported changes were statistically significant (p < 0.05).
Chromatin immunoprecipitation (ChIP)
ChIP assays were performed essentially as previously described 21 
Antisense transcription analysis
Total RNA was isolated from EA.hy926 and HepG2 cells using the RNeasy mini kit (Qiagen). RT-PCR was performed using the SuperScript III First-Strand Synthesis System (Invitrogen) and primers that specifically annealed to either sense or antisense sequences in hEPCR exons 1 and 2. Thereafter nested PCR was performed on all first strands using the same primer pair. The identity of amplified sequences was confirmed by sequencing. The 5' origin of the hEPCR antisense transcripts was determined by 5'-RACE (Invitrogen). The sequences of primers are presented in Supplementary Data.
Transgene preparation and transgenic mice
For generation of transgenic mice, transgene sequences were excised from vectors, purified and microinjected at 4 ng/ml in 10 mM Tris (pH7.4), 0.1 mM EDTA into pronuclei of fertilized eggs from C57B1/10 x CBA/Ca mice using standard techniques 22 . For analysis of reporter gene expression during embryogenesis, recipient females were sacrificed at E11.5-13.5, and the embryos were whole-mount stained using X-gal. Thereafter, X-gal positive embryos were dehydrated, wax-embedded, sectioned, dewaxed, and counterstained with eosin (BDH). For generating transgenic lines, the offspring following microinjections were biopsied 3-4 weeks after birth and genotyped for integration of the transgene using PCR. Transgenic founders were crossed with wild-type mice to generate non-chimeric transgenic mice. For tissue analysis, adult transgenic mice were sacrificed by cervical dislocation, and organs harvested. Tissues were rinsed in PBS/2 mM MgCl 2 , fixed in 4% paraformaldehyde/PBS at 4°C for 3 hours, cryoprotected in 30% sucrose/PBS/MgCl 2 at 4°C for 4 hours, mounted in OCT (BDH), snap-frozen in liquid nitrogen-cooled isopentane, and stored at -70°C. 10 µm cryosections were taken for X-gal staining.
Results
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The proximal promoter (PP) alone is incapable of directing cell-specific gene expression in vivo.
To assess PP transcriptional activity in vivo, transgenic mice were generated in which LacZ expression was directed by PP (-2336 to -9 bp relative to the translation start site), or truncations thereof. Of seventeen separate transgenic lines, thirteen exhibited germ line transmission of the transgene (Table   1 ). In eight of these, no β-galactosidase activity was detected in adult transgenic tissues. In the five remaining lines, LacZ expression was ectopic and non-reproducible. Similarly, LacZ expression was either ectopic or absent from embryonic transgenic tissues. Failure of PP to direct EPCR-like transcription in transgenic mice suggested that additional DNA elements outside of this 2.3 kb region are required for EC specificity in vivo.
DNaseI hypersensitive sites around the hEPCR locus
Previously, DH site mapping between -4.7 and +18.2 kb relative to the hEPCR ATG start codon identified DH sites within PP (PPHS) and the second intron (+2.9HS) of hEPCR ( Figure 1A kb either side of hEPCR. Apart from the EPCR coding regions and the PPHS sequence, only two nonrepetitive sequences were found to be conserved between human and mouse. Significantly, one 130 bp conserved region (CR) (-5657 to -5527 bp) was located within -5.5HS. This region, termed -5.5HSCR, exhibited 75% sequence identity with its murine counterpart (located -8.3 kb relative to the mEPCR translation start site). In conjunction with its hypersensitivity, this suggested a functional role for this sequence. The second conserved region was a very short (~40 bp) sequence located within intron 1 of hEPCR and did not correspond to a DH site. The +2.9HS was not conserved between species.
-5.5HS acts as a classical enhancer in vitro.
As both DH site mapping and comparative genomics suggested that -5.5HS might be a transcriptional regulatory element, we investigated its function in vitro. For this, the -5.5HS sequence (~500bp) was cloned, in either the sense (s) or antisense (as) orientation, upstream of SV40P linked to SEAP. In EA.hy926 cells, -5.5HS/s and -5.5HS/as enhanced SV40P-directed transcription by 1.6-and 1.9-fold, respectively ( Figure 2A ). Similar data were obtained using HUVEC (not shown). In HepG2 cells, For personal use only. on August 16, 2017 . by guest www.bloodjournal.org From SV40P-driven transcription was increased 1.8-and 2.1-fold by -5.5HS/s and -5.5HS/as, respectively. In EA.hy926 cells, -5.5HS/s and -5.5HS/as also enhanced PP-directed transcription by 2.2-and 2-fold respectively ( Figure 2B ). -5.5HS did not affect the transcriptional activity of PP in HepG2 cells (not shown), as PP was inactive in these cells. These results demonstrate that -5.5HS acts as a classical enhancer in vitro.
-5.5HSCR is responsible for -5.5HS activity.
To delineate the region(s) within -5.5HS responsible for its enhancer activity, we assessed the function of various -5.5HS fragments. Whereas the fragments encompassing the 130 bp -5.5HSCR were all similarly active to the ~500 bp -5.5HS ( Figure 2C ), those lacking -5.5HSCR lost all enhancer activity (not shown). We thus surmised that its function was primarily attributable to cis-elements contained within this conserved region.
-5.5HSCR contains cis-elements specifically occupied in EC.
Cell-specific occupancy of cis-elements within the -5.5HSCR by trans-acting factors was determined by in vivo DMS footprinting of both DNA strands of -5.5HSCR in different cell types. The elements that were footprinted in EC, but not in HepG2 cells ( Figure 3A ), corresponded to putative binding sites for Ets, GATA, and Tal1 (also known as SCL) transcription factors ( Figure 3B ). These motifs were also highly conserved in the murine sequence ( Figure 3C ). 
Potential role of +2.9HS in hEPCR regulation.
The transcriptional function of the non-conserved +2.9HS, which was strongly hypersensitive in HepG2 cells but only weakly so in HUVEC, was examined in transfection studies. In the sense orientation, the +2.9HS sequence (+2.9HS/s) did not augment SV40P-directed transcription in EA.hy926 cells, and did so only marginally in HepG2 cells ( Figure 5A ). In contrast, the antisense sequence (+2.9HS/as) enhanced transcription by 2.3-and 2.6-fold in EA.hy926 and HepG2 cells, respectively ( Figure 5A) . Similarly, +2.9HS/as imparted a 1.5-fold increase in PP-directed transcription in EA.hy926 cells, whilst +2.9HS/s did not affect PP activity ( Figure 5B ). This orientation dependence demonstrated that +2.9HS was not a classical enhancer. We hypothesised that it might negatively regulate hEPCR expression through autonomous initiation of antisense transcription. We assessed whether +2.9HS/as was capable of directing transcription. A SEAP-encoding construct in which +2.9HS/as was the only control element was generated. The promoter activity of +2.9HS/as was strong in HepG2 cells (comparable to that of PP in EA.hy926 cells), but weak in EA.hy926 cells ( Figure 5C ).
Furthermore, hEPCR antisense RNA transcripts were identified in both EA.hy926 and HepG2 cells by strand-specific reverse transcription PCR ( Figure 5D ). Using 5'-RACE, these antisense transcripts were found to originate close to +2.9HS near the end of exon 2 (Supplementary Data), implying that +2.9HS
may direct antisense transcription of hEPCR, and could be involved in hEPCR silencing.
kb of the hEPCR 5'-flanking region (encompassing -5.5HS and PP) directs reporter gene expression to the endothelium in vivo.
Having shown that by itself PP was unable to direct LacZ expression to the endothelium of transgenic mice, we evaluated whether an extended hEPCR promoter fragment that included -5.5HS would be capable of driving EC-specific transcription. Transgenes were generated in which LacZ expression was directed by 6 kb of the hEPCR 5'-flanking region (encompassing both PP and -5.5HS). Prior to generating transgenic mouse lines, LacZ expression in transgenic embryos (E11.5-13.5) was analysed.
Three out of six transgenic embryos exhibited strong β-galactosidase activity in the umbilical vessels, following whole-mount X-gal staining ( Figure 6A & B, Table 1 ). Tissue sections taken from these embryos confirmed LacZ expression by the EC of the umbilical vessels ( Figure 6B ), and also revealed β-galactosidase activity in the EC of certain large vessels (including aorta, vena cava, and large embryonic placental vessels) ( Figure 6D-G) . Reporter gene activity was also specifically detected in EC of certain smaller vessels in and around the brain, the developing spinal cord and between rib primordia ( Figure 6H & I) . In the remaining three transgenic embryos, no LacZ expression was detected in any location. Thereafter, transgenic lines were generated to assess the transcriptional function of -5.5HS with PP in adult mice. Of the twelve independent lines generated, ten exhibited germ line transmission of the transgene (Table 1) . In 60% (6/10) of these, no LacZ expression was detected. In all of the remaining four lines, however, β-galactosidase activity was specifically and consistently targeted towards the EC of the aorta and vena cava ( Figure 6J -L).
-5.5HS acts as an autonomous EC-specific enhancer in vivo.
To determine if it was -5.5HS that conferred EC-specificity to the 6 kb hEPCR promoter fragment, a transgene was generated in which the -5.5HS sequence was placed upstream of LacZ driven by the heterologous SV40P. Previously, it has been demonstrated that the SV40P does not drive specific transcription in transgenic embryos in the absence of a specific enhancer 25 . Four transgenic embryos were generated (Table 1) . Tissue sections of all of these revealed β-galactosidase activity in EC of various vascular beds, including large vessels such as the aorta, the vena cava, the hepatic vein and the umbilical vessels ( Figure 7A-H) . Reporter gene activity was also detected in smaller vessels surrounding the spinal cord ( Figure 7E) , and in the developing vascular networks surrounding the brain. LacZ expression was seen in the endothelium of all transgenic embryos, suggesting that its ECspecificity was independent of the site of transgene integration. These data confirm that -5.5HS is able
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Parallel analyses of the function of the 40 bp conserved sequence in intron 1 failed to reveal any role for this element in specific gene regulation (data not shown).
Discussion
Despite considerable progress in our knowledge of EC gene regulation and vascular bed specificity [26] [27] [28] [29] , there has been incomplete understanding of the mechanisms targeting the expression of genes such as EPCR to large vessel EC. In a study by Gu et al, transgenic mice were generated which expressed the green fluorescent protein under the control of mEPCR promoter fragments (extending up to -1080 bp).
However, that study failed to observe any fluorescence of this reporter protein that might allow the assessment of cellular specificity in vivo 14 . The present study investigates the transcriptional regulation of hEPCR, and is the first to elucidate the mechanisms underlying its EC-specific expression. Ets, GATA, and Tal1 transcription factors are expressed in both EC and HSC [34] [35] [36] , suggesting that they might contribute to a common mechanism of hEPCR regulation. In vivo DMS footprinting of the -5.5HSCR revealed that the Ets, GATA, and Tal1 motifs were occupied by trans-acting factors in EC but not in HepG2 cells. ChIP assays for these factors performed with the murine MS1 EC line demonstrated binding of the Ets (Ets2, Erg, Elf1, and Fli1), GATA2, and Tal1 transcription factors to their cognate motifs in the murine region homologous to -5.5HSCR.
The hEPCR PP failed to drive cell-specific transcription in vivo. However, using 6 kb of the hEPCR 5'-flanking region that included both PP and -5.5HS, strong, specific, and reproducible reporter gene expression was directed to the large vessel endothelium. This included the aorta, umbilical vessels, and selected small vessels surrounding the developing spinal cord and brain. The contrast between these findings and the findings obtained with PP alone strongly suggested that -5.5HS played a critical role in targeting EC-specific transgene expression. In each of the four independent adult transgenic lines expressing LacZ, β-galactosidase activity was limited to the endothelium of the aorta and vena cava,
, the 6 kb promoter fragment was capable of discriminating between large and small vessels, a functionality that has not been demonstrated for any other promoter fragment. The more restricted transgene expression in adult mice possibly reflects differences in gene regulation between embryonic and adult tissues 37 .
To confirm that it was the -5.5HS that conferred EC-specificity to the 6 kb hEPCR promoter, -5.5HS was coupled to the heterologous SV40P. In transgenic embryos, high-level reporter gene expression was reproducibly directed to EC, demonstrating that, by itself, the -5.5HS enhancer contains the regulatory sequences necessary to impart vascular specificity, and thus functions as an autonomous ECspecific enhancer. Other enhancers have been shown to autonomously direct transcription to the endothelium of transgenic embryos 27, 32, [38] [39] [40] , but -5.5HS is the first human enhancer capable of targeting transcription to both embryonic and adult EC. Moreover, to our knowledge, -5.5HS is the first regulatory element capable of specifically targeting transcription to large vessel EC. As such, it may provide a valuable tool for the development of a gene expression unit that specifically targets large vessels, which are the principal site of atherosclerosis and many vascular diseases.
A recent study by Balazs et al. identified abundant EPCR expression on primitive HSC, and demonstrated it to be an excellent marker for the identification of such cells from murine bone marrow 13 . We hypothesise that -5.5HS contains the regulatory elements necessary to target gene expression not only to EC, but potentially also to HSC. The hypersensitivity of -5.5HS in immature haematopoietic cells, and the detection of β-galactosidase in small numbers of cells within the bone marrow of transgenic mice generated with the -5.5HS-SV40P-LacZ construct, both support this
hypothesis. An ontogenic rationale is available for the proposed dual endothelial-haematopoietic function of -5.5HS as the development of blood and endothelium are known to be intertwined 41 . In the early embryo, the fate of differentiation of the haemangioblast into either an HSC or an EC is thought to be dictated by the combinatorial effects of the Tal1 and Flk1 genes 42 . Together with these genes, the Fli1 and PRH genes contribute to the transcriptional regulation of embryonic HSC and EC formation 40 .
Interestingly, the Tal1, Flk1, Fli1 and PRH genes are all governed by autonomous enhancers with dual HSC/EC activity 32, [38] [39] [40] . Furthermore, the activity of each of these enhancers is dependent on ciselements similar to those present within -5.5HS, namely Ets, GATA, and Tal1 motifs. In light of this, we propose a model in which -5.5HS targets hEPCR expression to primitive stem cells with dual specification potential, and in which hEPCR expression is progressively lost as these cells embark into haematopoietic specification. Of the autonomous HSC/EC enhancers mentioned above, only the murine Tal1 +19 kb enhancer has been shown capable of targeting transgene expression to adult RT-PCR was performed on total RNA from EA.hy926 or HepG2 cells using strand-specific primers that specifically amplified transcripts spanning hEPCR exons 1 and 2. Nested PCR and electrophoresis was used to visualise amplified sequences. The identity of the amplified RNA transcripts (sense and antisense) was confirmed by sequencing. Transgenic mice containing 6 kb of the hEPCR 5'-flanking region coupled to LacZ were generated. Embryos (A-I) and adult tissues (J-L) were analysed. Embryos were harvested at E12.5 and wholemount stained with X-gal (A & B). Thereafter stained embryos were wax embedded, sectioned and counter-stained with eosin (C-I). Sites of LacZ expression are dark blue (green arrows). In wholemount stained embryos, staining in the umbilical vessels was apparent (A & B), which was confirmed as endothelial in tissue sections (C). Transgene expression was also specifically detected in EC of large placental veins (D), aorta (E & F), and certain other larger veins and arteries (G). EC-specific expression was also seen in small vessels surrounding the spinal cord (H) and in the developing brain (I). Tissues from adult transgenic mice were stained with X-gal and counter-stained with haematoxylin (J-L). Reporter gene expression was specifically detected in the endothelium lining the aorta and vena cava (J-L). Transgenic embryos generated with LacZ under the control of -5.5HS/SV40P were harvested at ~E12.5, whole-mount stained with X-gal, sectioned, and counter-stained with eosin. Sites of LacZ expression are dark blue (green arrows). In 4/4 transgenic embryos reporter gene expression was specifically detected in EC, including those of the aorta and vena cava (A & B). In one embryo, very strong staining of the endocardium lining the chambers of the developing heart was seen (A & C). Transgene expression was also specifically detected in EC of umbilical vessels (D), small vessels surrounding the spinal cord (E), and in the hepatic vein (H). In 2/4 embryos, strong staining in a small number of bone marrow (BM) cells was seen (E-G). Table 1 : Summary of reporter gene distribution in transgenic mouse lines. The number of transgenic mouse lines exhibiting germline transmission are given. Of these, the number demonstrating reporter gene expression in given locations are stated (* of the 3 embryos exhibiting large vessel EC expression, 2 of these also showed small vessel EC reporter gene activity). For the -5.5HS/SV40P analysis, only transgenic embryos generated following microinjection were analysed. 
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